Search:
Scroll to top
Tag: evidence based
08/17/2023

Dartmouth’s Latin American Community Explores Innovation

Article Excerpt: Over the past decade, Dartmouth has formed multiple partnerships in Latin America. The center that (Lisa) Marsch directs— the only National Institute on Drug Abuse-designated center of excellence in digital therapeutics—is collaborating with researchers, insurers, and patient advocacy groups in Latin America as well as government organizations, such as the Ministry of Health in Colombia and National Institute of Mental Health in Peru, to create a new mental health service delivery model for Latin America that will provide better evidence-based care.

Full Article: https://tinyurl.com/r9wpyxzz

Article Source: Dartmouth News

Posted in: Dissemination & Implementation, Regulation & Policy // Tagged: ; ; ; ; ; ; ; ; ;
07/12/2023

Making Digital Interventions Accessible and Affordable

Article Excerpt: As the nation grapples with soaring demand for mental health services amid a provider shortage, more psychologists are considering the benefits of digital therapeutics—evidence-based interventions available to patients on their mobile devices. These tools have the potential to help people struggling with substance use disorders, anxiety, insomnia, and other conditions. But there is a major hurdle blocking widespread access: Using digital therapeutics in practice is not usually covered by health insurance. The costs for the software alone can range from approximately $300 to $1,500 annually—fees that are out of reach for many patients.

Full Article: https://tinyurl.com/23dws648

Article Source: American Psychological Association

Posted in: Emerging Technologies, Regulation & Policy // Tagged: ; ; ; ; ; ; ; ; ; ;
06/21/2023

ISPOR 2023 Trinity Panel: Enabling Patient Access to Digital Therapeutics – The Optimal Approach?

Article Excerpt: Monica Martin de Bustamante, Sr. Partner of Trinity’s Evidence, Value, Access, and Pricing (EVAP) team, moderated an exciting conversation at ISPOR 2023 Global in Boston earlier this month. Monica spoke with Lisa Marsch, Ph.D., Benjamin Parcher, PharmD, MS, and Fulton Velez, MD, MS, MBA, all experts in the field of Digital Therapeutics (DTx), about the role of evidence development in the approval of DTx to date, and what evidence development requirements could look like in the next five years.

Full Article: https://tinyurl.com/bp8ap3re

Article Source: Trinity Life Sciences

Posted in: Methodologies & Analytics, Regulation & Policy // Tagged: ; ; ;
01/26/2023

Geisel Launches New Center for Implementation Science

Article Excerpt: Despite the many advances made in academic medicine in recent decades, successfully applying what is learned in research to patient care remains a major challenge. For example, it takes, on average, 17 years for research to reach clinical practice. And most evidence-based guidelines are adopted only about 25 percent of the time. With the establishment of the new Dartmouth Center for Implementation Science (DCIS) at the Geisel School of Medicine, community partners across the Dartmouth enterprise will work to help close those gaps. “Implementation science is an emerging area of multidisciplinary research that focuses on moving scientific evidence into routine practice,” explains Jeremiah Brown, PhD, a professor of epidemiology at Geisel and founding director of DCIS. In addition to Brown, the DCIS leadership team includes co-directors Sarah Lord, PhD, associate professor of psychiatry and biomedical data science, Kelly Aschbrenner, PhD, associate professor of psychiatry and principal scientist at Dartmouth Health, and program manager Sherry Owens, PhD. Genevieve Shaefer ’26, the first Women In Science Project (WISP) intern for DCIS, will be working with the team on campus engagement and training.

Full Article: https://tinyurl.com/mhxzk79r

Article Source: Dartmouth Geisel School of Medicine News

Posted in: Dissemination & Implementation // Tagged: ; ; ; ; ;
01/25/2023

NCI-Funded Centers Study New Ways to Apply Telehealth Across Cancer Care

Article Excerpt: …with the initial urgency of the pandemic in the past, public health agencies including NCI are examining ways to maximize the benefits of telehealth, from cancer screening to survivorship. NCI’s former director, Norman “Ned” Sharpless, MD, inspired agency officials to undertake a widespread effort to accelerate and optimize use of telehealth, (Robin C.) Vanderpool (chief of the health communication and informatics research branch in the division of cancer control and population sciences at NCI) said. “Dr. Sharpless came to our division and said, ‘We need take advantage of this one silver lining coming out of the pandemic.’” she said. “‘We need to understand what’s happening in the cancer space with telehealth.’”

Full Article: https://tinyurl.com/4r8h2yyu

Article Source: Healio

Posted in: Emerging Technologies, Methodologies & Analytics // Tagged: ; ; ; ; ; ;
10/23/2022

Can VR Act as A Digital Therapeutic?

Article Excerpt: Our digital, two-dimensional lives leave little room for focus. Our eyes dart from screen to screen over the course of the day as notifications and messages draw our attention away from tasks, from relaxation, from the faces of our loved ones. Through all of its flatness, our digital lives are dominated by distraction—so much so that we can sometimes forget to breathe. Finding lasting inner peace from within this flattened world can be a neurological nightmare. Mindfulness and meditation apps, digital health’s answer in the last decade, use many of the same engagement methods that have propelled other consumer applications like games and fitness apps to success. Strategies like achievements and social connectivity have kept many users coming back to engage in evidence-based, clinically effective therapies. But even the most effective and engaging mindfulness apps can’t transcend the noise and distraction of our everyday lives.

Full Article: https://tinyurl.com/mryfpr8m

Article Source: Fast Company

Posted in: Emerging Technologies // Tagged: ; ; ; ; ;
04/26/2022

Biden’s National Drug Control Strategy Prioritizes Digital Therapeutics Reimbursement for Substance Use

Article Excerpt: The Biden Administration is encouraging new digital therapeutics reimbursement strategies in both the public and private sector as part of its National Drug Control Strategy report. In the plan the White House pitches digital therapeutics, evidence-based treatments delivered through software interventions to treat or manage a condition, as a potential tool to help expand access to substance use disorder (SUD) treatments. The reimbursement plans, which was first spotted by Exits and Outcomes, was part of a larger plan to tackle substance use disorders.

Full Article: https://tinyurl.com/mr82ered

Article Source: Behavioral Health Business

Posted in: Emerging Technologies, Regulation & Policy // Tagged: ; ; ; ; ;
02/28/2022

Digital Therapeutics Should Be Regulated With Gold-Standard Evidence

Article Excerpt: There is enormous growth in the digital health sector, illustrated by huge capital investment, and a massive proliferation of mental and behavioral health apps and associated marketing claims. We are particularly concerned about one component of this sector, namely “software as a medical device”, which the Food and Drug Administration (FDA) defines as “software intended to be used for one or more medical purposes,….without being part of a hardware medical device,” and where the purpose is “treatment or alleviation of disease.” This new approach to treatment, increasingly referred to as digital therapeutics (DTx), has the potential to transform mental health care. The global DTx market was valued at more than $3.5 billion in 2020 and is projected to reach $23.5 billion by 2030. According to industry reporting, the largest number of DTx programs today are related to mental health, and most FDA submissions for DTx use cognitive behavioral therapy to promote behavior change in conditions ranging from insomnia to substance use disorder. The opportunity for innovation is clear. However, there are challenges that must be addressed.

Full Article: https://tinyurl.com/2myajfns

Article Source: Health Affairs

Posted in: Regulation & Policy // Tagged: ; ; ; ; ; ; ; ; ; ;
08/05/2021

William C. Torrey, MD, Appointed to Raymond Sobel Professorship

Article Excerpt: William C. Torrey, MD, interim chair and professor of psychiatry and of health policy and clinical practice at the Geisel School of Medicine, has been appointed to the Raymond Sobel Professorship in Psychiatry for a two-year term effective June 1, 2021. Torrey is dedicated to improving care for adults with severe mental illness and integrating psychiatric care into primary care. His research, writing, and teaching focus on supported employment, integrated services for adults with co-occurring substance use disorders and severe mental illnesses, evidence-based practice implementation, collaborative care in primary care, and shared decision making in medication management for adults with psychiatric and addictive illnesses.

Full Article: https://tinyurl.com/kzrbzv9u

Article Source: Dartmouth Geisel School of Medicine News

Posted in: Uncategorized // Tagged: ; ; ; ; ; ; ; ;